Dyspareunia: Pain During Intercourse and Its Multiple Origins

Dyspareunia is defined as persistent or recurrent pain during or after sexual intercourse, with intensity sufficient to cause personal suffering or relational dysfunction. It affects 10%–20% of women at some point in reproductive life, with a peak in perimenopause (vulvovaginal atrophy) and in women with endometriosis. In men it is less prevalent (2%–4%), associated mainly with phimosis, prostatitis, or penile conditions.

10–20%
PREVALENCE IN WOMEN AT SOME POINT IN LIFE (ESTIMATE)
frequently underdiagnosed condition
~40–54%
POSTMENOPAUSAL PREVALENCE WITHOUT HRT (REPORTED RANGE)
associated with vulvovaginal atrophy
~30%
WOMEN WITH ENDOMETRIOSIS WHO HAVE DEEP DYSPAREUNIA (REPORTED RANGE)
frequently underestimated symptom
years
SIGNIFICANT DIAGNOSTIC DELAY
dyspareunia is rarely reported spontaneously

Conventional Treatments

Treatment of dyspareunia is necessarily guided by etiology. Correct diagnosis (gynecologic, dermatologic, neurologic) precedes any treatment. The multimodal approach is the most effective — especially when there is a central component (sensitization, catastrophizing).

TREATMENTS BY TYPE OF DYSPAREUNIA

TYPEMAIN TREATMENTROLE OF ACUPUNCTURE
Postmenopausal vulvovaginal atrophyTopical estrogen (vaginal cream or ovule); oral ospemifeneComplementary: SP-6, KI-3, CV-4 to support Yin; improvement in vaginal thermal sensation
Vestibulodynia / provoked vulvodyniaTopical lidocaine, topical amitriptyline, pelvic floor physiotherapy, vestibulectomyBL-32, SP-6, LR-5 — sacral neuromodulation of the pudendal nerve; reduction of allodynia to genital probing
Dyspareunia from endometriosisHormonal or surgical treatment of endometriosisSP-8, CV-4, LR-3 — control of pelvic central sensitization; complementary
VaginismusProgressive dilators, psychotherapy/sexology, botulinum toxin in the levatorPC-6, SP-6 — reduction of anticipatory anxiety; complement to behavioral treatment
Male dyspareuniaTreatment of prostatitis, phimosis, dermatosesBL-32, CV-3, SP-6 — pelvic analgesia; support for chronic prostatitis
Dyspareunia with central sensitizationAmitriptyline, duloxetine, pain psychotherapy (CBT)Acupuncture as a central modulator — reduces spinal excitability; complementary

How Acupuncture Works in Dyspareunia

Mechanisms in Dyspareunia

  1. Pudendal Nerve Neuromodulation (S2–S4)

    BL-32 and BL-33 (sacral foramina S2–S3) directly stimulate the roots that originate the pudendal nerve — the main afferent for pain in the vulva and perineum. Electroacupuncture at this point reduces the excitability of pudendal C and Aδ fibers, decreasing vulvar allodynia.

  2. Reduction of Levator Ani Spasm

    In vaginismus and dyspareunia with reflex muscle spasm, the levator ani muscle contracts involuntarily in anticipation of pain. Points such as SP-6 and BL-36 are believed to modulate spino-bulbo-spinal reflex pathways that inhibit this muscle — with a clinical target similar (but mechanism distinct) to that of botulinum toxin.

  3. Modulation of Central Sensitization

    In chronic dyspareunia, the dorsal horn S2–S4 becomes sensitized — amplifying all stimuli from the pelvic region. Acupuncture reduces spinal c-fos and NMDA expression, gradually desensitizing the central pain system. This central component explains why acupuncture improves dyspareunia even when the local cause has already been treated.

  4. Improvement of Vaginal Flow (Atrophy)

    In postmenopausal atrophic dyspareunia, CV-4 with indirect moxibustion and KI-3 increase pelvic flow and modulate the vaginal trophic response via the parasympathetic autonomic nervous system (S2–S4 → pelvic nerve → vaginal plexus). Studies show improvement in pH and lubrication.

BL32BL33 — Sacral Foramina (Pudendal Neuromodulation)

Needling in the S2S3 foramina with 2 Hz EA reaches the pudendal nerve roots. Same mechanism as implantable sacral neuromodulation (Interstim) — but noninvasive. Direct evidence in vestibulodynia and introital dyspareunia.

SP6 + LR5 — Reduction of Vulvar Allodynia

SP6 and LR5 form a neuromodulation pair specific to the vulva and vagina. LR5 lies over the femoral canal, near the sensory branch of the pudendal nerve.

Scientific Evidence

Modern Approach: Integration With Multimodal Treatment

Complement to Pelvic Floor Physiotherapy

Pelvic floor physiotherapy (biofeedback, dilators, pelvic floor release) is the first-line non-pharmacologic treatment for vaginismus and muscular dyspareunia. Acupuncture reduces the central tension that hinders progress with dilators — potentiating physiotherapy results.

Postsurgical Dyspareunia

After hysterectomy, oophorectomy, endometriosis surgery, or prolapse repair, adhesions and partial denervation contribute to postsurgical dyspareunia. Acupuncture addresses residual sensitization and improves pelvic flow without additional surgical risk.

When to See a Medical Acupuncturist

Indications

Chronic dyspareunia (>3 months) with an identified cause already in treatment; central sensitization component; dyspareunia from endometriosis; postmenopausal atrophic dyspareunia as a complement to topical estrogen; postsurgical dyspareunia.

Protocol

8–12 weekly sessions as the initial cycle; reassessment by FSFI and VAS after 8 weeks; monthly maintenance after response. BL32BL33, SP6, LR5, CV4, GV20; 2 Hz EA at the sacral foramina for introital dyspareunia.

Frequently Asked Questions

FREQUENTLY ASKED QUESTIONS · 04

Frequently Asked Questions

Treating without a diagnosis is not recommended. Dyspareunia may be a symptom of endometriosis, PID, tumor, or other conditions that require specific treatment. The medical acupuncturist will take a history and, if the cause is not diagnosed, will refer to the gynecologist for investigation before initiating treatment.

Needling at the S2–S3 sacral foramina is performed by a physician with experience in pelvic anatomy. The needles are 0.25–0.30 mm in diameter — they do not cause nerve injury. There may be a sensation of tingling or radiation to the perineum during electroacupuncture — this is expected and indicates good localization. The procedure is safe when performed by a trained medical acupuncturist.

Acupuncture is not performed "during" intercourse. The benefit is cumulative — 8–12 weeks of treatment produce progressive and sustained reduction of dyspareunia. It is not a local anesthetic that acts at the moment of intercourse. Some patients report that the session performed on the day of, or the day before, a planned encounter helps by reducing the state of alertness and anticipatory muscle tension.

It should not replace it. Topical estrogen (vaginal cream or ovule) acts directly on atrophy — restoring epithelium, pH, and lubrication. Acupuncture can complement, contributing to modulation of pelvic flow, residual allodynia, and the central component of pain. The combination of topical estrogen with acupuncture tends to be more effective than any approach alone in atrophic dyspareunia of greater intensity, always under the gynecologist's direction.

Related Articles